genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Topics
Genome Editing
Page 3
Genome Editing
Artificial Intelligence
Bioprocessing
Cancer
Coronavirus
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
Genome Editing
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Genome Editing
GENcast: 3D Cell Models Push Drug Discovery Screening into High Gear
Genome Editing
GENcast: The Quiet Voice of Immunotherapy That’s Starting to Be Heard
CRISPR-Cas9 Alternatives: Cutting through the Boundaries of Gene Editing
Genome Editing
GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal
Genome Editing
First Fully Functional Yeast Chromosome Synthetically Designed
Genome Editing
CRISPR/Cas9 Can Now Edit RNA, Not Just DNA
Genome Editing
Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy
Genome Editing
Synthetic DNA as Easy as 1-2-3 with One-and-Done Enzymes
Genome Editing
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
Genome Editing
DNA Crosslink Repair Central to CRISPR Insert Success
Genome Editing
CRISPR Applications in Plants
Genome Editing
Unlocking the Potential of CRISPR-Based Gene Editing
Genome Editing
DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from...
1
2
3
4
...
170
Page 3 of 170
Scroll Up
Scroll Up
![Sacharomyces cerevisiae cells under DIC microscopy. [Masur - Wikipedia]](https://www.genengnews.com/wp-content/uploads/2018/08/Masur_WikipediaS_cerevisiae_under_DIC_microscopy8753321861-324x160.jpg "First Fully Functional Yeast Chromosome Synthetically Designed")
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-324x160.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
